Grant: Discovery Grants Program - Individual
École Polytechnique de Montréal
$82,000.00
Development of inelastic scattering detection techniques and artificial intelligence approaches for surgical oncology applications
FY 2024-25
Summary
Cancer is the first cause of death in developed countries and is responsible for more than 30% of deaths in Canada. Human diseases associated with solid tumors are usually discovered by computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), single positron emission tomography (SPECT) and ultrasound (US). While the resulting medical images can characterize the location(s) and anatomical relationships of the tumors, they are often unable to specifically identify their nature and detect their full spatial extent. After a diagnosis, surgery (resection of pathological tissue) is the first-line therapy, but its effectiveness is reduced because of the difficulty to determine where a tumor ends, and where healthy tissue begins. The inability to detect all pathological cells can lead to disease recurrence, resulting in multiple procedures being required to remove an entire tumor. Avoiding damage to critical structures (e.g., nerves, blood vessels) while maximizing the volume of resected cancer is a pressing problem because unintended healthy tissue damage leads to longer hospital stays, re-operations, pain, and trauma for patients.
Diseased and normal tissue exhibit different morphological, molecular, and biochemical characteristics that can be quantified based on optical properties derived from spectroscopic data associated with inelastic Raman scattering (lipids, proteins, DNA/RNA). This Natural Sciences and Engineering program aims to develop new optical spectroscopy instruments and biophysical/statistical models allowing highly sensitive and accurate molecular tissue characterization with the perspective of improving cancer detection and classification for various organ sites including brain, breast, lung, and prostate. Specifically, this project will lead to the development of: 1) real-time single-point Raman spectroscopy photonic devices adapted for applications requiring endoluminal access for in vivo tissue characterization, 2) whole-specimen tumor margins assessment with surface/subsurface detection from hyperspectral imaging and spatial-offset Raman spectroscopy, 3) high-speed intraoperative (in vivo) wide-field multi-spectral Raman imaging in the form of a compact hand-held device, 4) new spectromic approaches using untargeted spatiomolecular sub-cellular resolution maps of fresh biopsy samples from stimulated Raman spectroscopy for automated pathological assessment and stratification in terms of genetic profile. This proposal will set up the stage for a new generation of cancer detection technologies around a single core technology: Raman spectroscopy. It will contribute to expand our knowledge of tissue biochemistry in oncology with the potential to improve patient survival prospects and health care cost-effectiveness. This will be accomplished through advances in biomedical optics that can reduce inefficiencies and costs of procedures by decreasing the number of repeat surgeries.
Program
Discovery Grants Program - Individual
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2024-06453
Name nom
Leblond, Frederic
Department département
Engineering Physics
Organization id
64
Institution établissement
École Polytechnique de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2024
Award amount
82000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1505
Committee name en
Physics
Committee name fr
Physique
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Development of inelastic scattering detection techniques and artificial intelligence approaches for surgical oncology applications
Keywords
raman spectroscopy; tissue optics; machine learning; pathology; cancer; lasers; fluorescence; surface-enhanced raman spectroscopy; multi-spectral imaging; hyperspectral imaging
Application summary
Cancer is the first cause of death in developed countries and is responsible for more than 30% of deaths in Canada. Human diseases associated with solid tumors are usually discovered by computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), single positron emission tomography (SPECT) and ultrasound (US). While the resulting medical images can characterize the location(s) and anatomical relationships of the tumors, they are often unable to specifically identify their nature and detect their full spatial extent. After a diagnosis, surgery (resection of pathological tissue) is the first-line therapy, but its effectiveness is reduced because of the difficulty to determine where a tumor ends, and where healthy tissue begins. The inability to detect all pathological cells can lead to disease recurrence, resulting in multiple procedures being required to remove an entire tumor. Avoiding damage to critical structures (e.g., nerves, blood vessels) while maximizing the volume of resected cancer is a pressing problem because unintended healthy tissue damage leads to longer hospital stays, re-operations, pain, and trauma for patients.
Diseased and normal tissue exhibit different morphological, molecular, and biochemical characteristics that can be quantified based on optical properties derived from spectroscopic data associated with inelastic Raman scattering (lipids, proteins, DNA/RNA). This Natural Sciences and Engineering program aims to develop new optical spectroscopy instruments and biophysical/statistical models allowing highly sensitive and accurate molecular tissue characterization with the perspective of improving cancer detection and classification for various organ sites including brain, breast, lung, and prostate. Specifically, this project will lead to the development of: 1) real-time single-point Raman spectroscopy photonic devices adapted for applications requiring endoluminal access for in vivo tissue characterization, 2) whole-specimen tumor margins assessment with surface/subsurface detection from hyperspectral imaging and spatial-offset Raman spectroscopy, 3) high-speed intraoperative (in vivo) wide-field multi-spectral Raman imaging in the form of a compact hand-held device, 4) new spectromic approaches using untargeted spatiomolecular sub-cellular resolution maps of fresh biopsy samples from stimulated Raman spectroscopy for automated pathological assessment and stratification in terms of genetic profile. This proposal will set up the stage for a new generation of cancer detection technologies around a single core technology: Raman spectroscopy. It will contribute to expand our knowledge of tissue biochemistry in oncology with the potential to improve patient survival prospects and health care cost-effectiveness. This will be accomplished through advances in biomedical optics that can reduce inefficiencies and costs of procedures by decreasing the number of repeat surgeries.